Skip to main content

Marijuana use does not affect weight loss or complication rate after bariatric surgery



Marijuana use has been legalized in several states. It is unclear if marijuana use affects weight loss outcomes or complication rates following bariatric surgery. The purpose of this study was to determine if patients who use marijuana had higher complication rates or lower weight loss compared with non-users.


All patients at a single institution who underwent primary bariatric surgery between July 2015 and July 2020 at a single institution after the legalization of marijuana within the jurisdiction were included. Data regarding marijuana use, weight and complications were abstracted retrospectively. Differences between groups were evaluated with Wilcoxon Rank-Sum tests and Fisher Freeman Halton test. Trends for marijuana use over time was evaluated with simple linear regression on summary data.


1107 patients met inclusion criteria. 798 (73.3%) were never users, 225 (19.4%) were previous users, and 84 (7.2%) were active users. The proportion of active users and previous users increased over time, with significantly more prior marijuana use reported in more recent years (p = 0.014). Active users had significantly higher pre-procedural BMIs than never users: 48.7 vs. 46.3 (p = 0.03). Any marijuana use (active and previous users) was associated with higher preoperative weight compared to never: 136.4 kg vs. 130.6 kg (p = 0.001). Overall complication rate was low in all groups, and there was no difference in the rates of any complications. Active and previous users tended to lose less weight than never users, but this was not statistically significant (p = 0.17).


Active and prior marijuana users tend to have higher BMIs on presentation, but use was not associated with complications or percent weight loss. The incidence of patient reported marijuana use is increasing in the study population. More studies on the effects of marijuana use in this patient population are warranted.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2


  1. Bae H, Kerr DCR (2020) Marijuana use trends among college students in states with and without legalization of recreational use: initial and longer-term changes from 2008 to 2018. Addiction 115(6):1115–1124.

    Article  PubMed  Google Scholar 

  2. Gnofam M, Allshouse AA, Stickrath EH, Metz TD (2020) Impact of Marijuana legalization on prevalence of maternal marijuana use and perinatal outcomes. Am J Perinatol 37(1):59–65.

    Article  PubMed  Google Scholar 

  3. Boggs DL, Nguyen JD, Morgenson D, Taffe MA, Ranganathan M (2018) Clinical and preclinical evidence for functional interactions of cannabidiol and δ(9)-tetrahydrocannabinol. Neuropsychopharmacology 43(1):142–154.

    CAS  Article  PubMed  Google Scholar 

  4. Trojniar W, Wise RA (1991) Facilitory effect of delta 9-tetrahydrocannabinol on hypothalamically induced feeding. Psychopharmacology 103(2):172–176.

    CAS  Article  PubMed  Google Scholar 

  5. Koch M (2017) Cannabinoid receptor signaling in central regulation of feeding behavior: a mini-review. Front Neurosci 11:293.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Verty AN, Stefanidis A, McAinch AJ, Hryciw DH, Oldfield B (2015) Anti-obesity effect of the CB2 receptor agonist JWH-015 in diet-induced obese mice. PLoS ONE 10(11):e0140592.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  7. Ignatowska-Jankowska B, Jankowski MM, Swiergiel AH (2011) Cannabidiol decreases body weight gain in rats: involvement of CB2 receptors. Neurosci Lett 490(1):82–84.

    CAS  Article  PubMed  Google Scholar 

  8. Sarwer DB, Allison KC, Wadden TA et al (2019) Psychopathology, disordered eating, and impulsivity as predictors of outcomes of bariatric surgery. Surg Obes Related Dis 15(4):650–655.

    Article  Google Scholar 

  9. King WC, Chen JY, Courcoulas AP et al (2017) Alcohol and other substance use after bariatric surgery: prospective evidence from a US multicenter cohort study. Surg Obes Related Dis 13(8):1392–1402.

    Article  Google Scholar 

  10. Williams AR (2020) Cannabis as a gateway drug for opioid use disorder. J Law Med Ethics 48(2):268–274.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Singh A, Saluja S, Kumar A et al (2018) Cardiovascular complications of marijuana and related substances: a review. Cardiol Ther 7(1):45–59.

    CAS  Article  PubMed  Google Scholar 

  12. Bauer FL, Donahoo WT, Hollis HW Jr et al (2018) Marijuana’s influence on pain scores, initial weight loss, and other bariatric surgical outcomes. Perm J 22:18–002.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Jung F, Lee Y, Manzoor S, Hong D, Doumouras AG (2021) Effects of perioperative cannabis use on bariatric surgical outcomes: a systematic review. Obes Surg 31(1):299–306.

    Article  PubMed  Google Scholar 

  14. Shockcor N, Adnan SM, Siegel A, Wise E, Zafar SN, Kligman M (2021) Marijuana use does not affect the outcomes of bariatric surgery. Surg Endosc 35(3):1264–1268.

    Article  PubMed  Google Scholar 

  15. Raebel MA, Newcomer SR, Reifler LM et al (2013) Chronic use of opioid medications before and after bariatric surgery. JAMA 310(13):1369–1376.

    CAS  Article  PubMed  Google Scholar 

  16. Kerr DCR, Bae H, Koval AL (2018) Oregon recreational marijuana legalization: changes in undergraduates’ marijuana use rates from 2008 to 2016. Psychol Addict Behav 32(6):670–678.

    Article  PubMed  Google Scholar 

  17. Cerda M, Wall M, Feng T et al (2017) Association of State recreational marijuana laws with adolescent Marijuana use. JAMA Pediatr 171(2):142–149.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Vidot DC, Prado G, De La Cruz-Munoz N, Spadola C, Cuesta M, Messiah SE (2016) Postoperative marijuana use and disordered eating among bariatric surgery patients. Surg Obes Related Dis 12(1):171–178.

    Article  Google Scholar 

  19. Suhre W, O’Reilly-Shah V, Van Cleve W (2020) Cannabis use is associated with a small increase in the risk of postoperative nausea and vomiting: a retrospective machine-learning causal analysis. BMC Anesthesiol 20(1):115.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  20. Chang SH, Stoll CR, Song J, Varela JE, Eagon CJ, Colditz GA (2014) The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003–2012. JAMA Surg 149(3):275–287.

    Article  PubMed  PubMed Central  Google Scholar 

Download references



Author information

Authors and Affiliations


Corresponding author

Correspondence to Farah Husain.

Ethics declarations


Tarin Worrest, C. Cole Malibiran, Jill Welshans, Elizabeth Dewey, and Farah Husain have reports no disclosures.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Worrest, T., Malibiran, C.C., Welshans, J. et al. Marijuana use does not affect weight loss or complication rate after bariatric surgery. Surg Endosc 36, 6931–6936 (2022).

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: